Citius Pharmaceuticals Inc (NQ: CTXR )
0.5950
+0.0217
(+3.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Citius Pharmaceuticals Inc
Analysts Hunt for Undervalued Biotech Stocks
July 17, 2024
Via Newsfile
Citius Pharmaceuticals (NASDAQ: CTXR) Spearheads the Global Cancer Immunotherapy Market
May 07, 2022
Via Get News
Exposures
Product Safety
Via AB Newswire
Exposures
Product Safety
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
November 14, 2023
Via ACCESSWIRE
Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies
May 03, 2021
Topics
Death
Exposures
Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.